Senores Pharmaceuticals IPO Day 3: Check GMP, price band, listing date and review

Analysts have recommended investors subscribe to the issue, citing attractive valuations and strong demand for pharmaceuticals. At the upper price band, the company is valued at a P/E ratio of 55x, with a market capitalization of Rs 1,801 crore following the equity share issue.